Kabipac Ringer Lactato Solución Para Perfusión

Ringer's lactate solution, the active ingredient in Kabipac Ringer Lactato Solución Para Perfusión, is an electrolyte solution presented as an isotonic crystalloid solution for intravenous use. It is used to replace fluid loss and correct electrolyte imbalances in patients with hypovolemia, dehydration, or during peri‑operative management.

GNH USA supplies Kabipac Ringer Lactato Solución Para Perfusión as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, clinics and other healthcare institutions worldwide.

Kabipac Ringer Lactato is an intravenous electrolyte solution used in the management of fluid and electrolyte disorders. - Fluid and electrolyte replacement: restores intravascular volume and corrects electrolyte deficits. - Hypovolemia: expands circulating volume to improve tissue perfusion. - Dehydration: rehydrates patients who have lost body fluids. - Perioperative fluid management: maintains hemodynamic stability during surgery.

Kabipac Ringer Lactato may be associated with infusion‑related adverse reactions.

Common Side Effects: - Injection site irritation: mild pain or erythema at the infusion site. - Transient hypernatremia: slight increase in serum sodium levels. - Hypokalemia: reduced potassium if administered rapidly without potassium supplementation. - Metabolic alkalosis: due to lactate conversion to bicarbonate.

Serious or Rare Side Effects: - Anaphylactic reaction: rare hypersensitivity requiring immediate medical intervention. - Fluid overload: risk of pulmonary edema in patients with cardiac or renal failure. - Severe electrolyte imbalance: possible hyperkalemia or hypercalcemia if dosing errors occur.

Before administering Kabipac Ringer Lactato, consider the following precautions. - Assess volume status: evaluate the patient’s fluid balance prior to infusion. - Monitor electrolytes: regularly check serum sodium, potassium and calcium during therapy. - Renal impairment: adjust infusion rate in patients with reduced kidney function. - Cardiac disease: avoid rapid infusion in individuals with heart failure risk. - Lactate metabolism: use cautiously in severe liver dysfunction. - Store at ambient temperature: keep in the original container, protect from light and moisture.

Kabipac Ringer Lactato can interact with other agents; review the following.

Major Interactions (Avoid): - Concurrent hypertonic saline: may cause severe hypernatremia. - Calcium‑containing solutions mixed together: risk of precipitation. - Blood products with citrate: may exacerbate calcium depletion.

Moderate Interactions (Monitor Closely): - Diuretics: may increase electrolyte loss, requiring close monitoring. - ACE inhibitors or ARBs: can affect potassium balance. - Insulin therapy: may shift potassium intracellularly, altering serum levels.